Paper
0
Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients: A Multicenter Cohort Study
Authors
Philipp Berning,Markus Maulhardt
Hristo Boyadzhiev,Anca Albici,Snjezana Janjetovic,Anna Saidy,Christian Schultze-Florey,Simon Call,Natalie Schub,Annamaria Brioli,Michael Daskalakis,Juliane Knust,Justin Hasenkamp,Matthias Stelljes,Cyrus Khandanpour,Ulrike Bacher,Christine Hanoun,Florian Heidel,Hans Reinhardt,Georg Lenz,Gerald Wulf,Friedrich Stölzel,Bastian Tresckow,Thomas Pabst,Evgenii Shumilov
+23 authors
,Christine SchmitzJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.